DK1307237T3 - Perfluoroalkyl-containing complexes with polar groups, process for their preparation and use - Google Patents

Perfluoroalkyl-containing complexes with polar groups, process for their preparation and use

Info

Publication number
DK1307237T3
DK1307237T3 DK01958005T DK01958005T DK1307237T3 DK 1307237 T3 DK1307237 T3 DK 1307237T3 DK 01958005 T DK01958005 T DK 01958005T DK 01958005 T DK01958005 T DK 01958005T DK 1307237 T3 DK1307237 T3 DK 1307237T3
Authority
DK
Denmark
Prior art keywords
perfluoroalkyl
preparation
polar groups
containing complexes
complexes
Prior art date
Application number
DK01958005T
Other languages
Danish (da)
Inventor
Johannes Platzek
Peter Mareski
Ulrich Niedballa
Bernd Raduechel
Hanns-Joachim Weinmann
Bernd Misselwitz
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Application granted granted Critical
Publication of DK1307237T3 publication Critical patent/DK1307237T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F19/00—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK01958005T 2000-08-11 2001-07-23 Perfluoroalkyl-containing complexes with polar groups, process for their preparation and use DK1307237T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10040858A DE10040858C2 (en) 2000-08-11 2000-08-11 Perfluoroalkyl-containing complexes with polar residues, process for their preparation and their use
PCT/EP2001/008500 WO2002013875A2 (en) 2000-08-11 2001-07-23 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof

Publications (1)

Publication Number Publication Date
DK1307237T3 true DK1307237T3 (en) 2007-07-02

Family

ID=7653176

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01958005T DK1307237T3 (en) 2000-08-11 2001-07-23 Perfluoroalkyl-containing complexes with polar groups, process for their preparation and use

Country Status (30)

Country Link
EP (1) EP1307237B9 (en)
JP (1) JP2004506026A (en)
KR (2) KR20030022381A (en)
CN (1) CN1468113A (en)
AR (1) AR035342A1 (en)
AT (1) ATE359093T1 (en)
AU (2) AU2001279777B2 (en)
BG (1) BG107541A (en)
BR (1) BR0113187A (en)
CA (1) CA2419259A1 (en)
CZ (1) CZ2003341A3 (en)
DE (2) DE10040858C2 (en)
DK (1) DK1307237T3 (en)
EE (1) EE200300060A (en)
ES (1) ES2284671T3 (en)
HR (1) HRP20030171A2 (en)
HU (1) HUP0300769A3 (en)
IL (1) IL154329A0 (en)
MX (1) MXPA03001286A (en)
NO (1) NO20030649L (en)
NZ (1) NZ524080A (en)
PL (1) PL365367A1 (en)
PT (1) PT1307237E (en)
RU (1) RU2289579C2 (en)
SK (1) SK286239B6 (en)
UA (1) UA74004C2 (en)
UY (1) UY26873A1 (en)
WO (1) WO2002013875A2 (en)
YU (1) YU10503A (en)
ZA (1) ZA200301947B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344704B2 (en) 2002-07-10 2008-03-18 Schering Ag Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi
DE10231799B4 (en) * 2002-07-10 2006-10-05 Schering Ag Use of perfluoroalkyl-containing metal complexes as contrast agents in MR imaging for the presentation of intravascular thrombi
DE102005033903B4 (en) * 2005-07-15 2007-08-09 Bayer Schering Pharma Ag Perfluoroalkyl-containing complexes, processes for their preparation, and their use and pharmaceutical compositions containing them
EP1904462A2 (en) * 2005-07-15 2008-04-02 Bayer Schering Pharma Aktiengesellschaft Complexes containing perfluoroalkyl, method for the production and use thereof
DE102005033902B3 (en) * 2005-07-15 2007-04-05 Schering Ag Perfluoroalkyl-containing complexes, processes for their preparation, and their use and pharmaceutical compositions containing them
DE102006049821A1 (en) 2006-10-18 2008-04-24 Bayer Schering Pharma Aktiengesellschaft New, well tolerated metal chelates, for use as radiodiagnostic, radiotherapeutic or NMR and X-ray diagnostic agents, contain chelator and perfluorinated polyethylene glycol residues
DE102007015598A1 (en) * 2007-03-29 2008-10-02 Heinrich-Heine-Universität Düsseldorf Use of fluorochemical compounds for diagnostic purposes using imaging techniques
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
CN110035996B (en) 2016-11-28 2022-08-09 拜耳医药股份公司 Novel highly relaxant gadolinium chelates for magnetic resonance imaging
RU2681319C1 (en) * 2017-10-27 2019-03-06 Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский экономический университет имени Г.В. Плеханова" (ФГБОУ ВО "РЭУ им. Г.В. Плеханова") Ultra-fibrous biopolymer material with bactericidal effect
KR20210095168A (en) 2018-11-23 2021-07-30 바이엘 악티엔게젤샤프트 Formulation of Contrast Media and Method for Preparing Same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4317588C2 (en) * 1993-05-24 1998-04-16 Schering Ag Macrocyclic metal complexes containing fluorine, process for their preparation and their use
DE19603033A1 (en) * 1996-01-19 1997-07-24 Schering Ag Perfluoroalkyl-containing metal complexes, processes for their preparation and their use in NMR diagnostics
DE19608278A1 (en) * 1996-02-23 1997-08-28 Schering Ag Pharmaceutical compositions containing perfluoroalkyl-containing metal complexes, and their use in tumor therapy and interventional radiology
DE19729013A1 (en) * 1997-07-03 1999-02-04 Schering Ag Oligomeric, perfluoroalkyl-containing compounds, processes for their preparation and their use in NMR diagnostics
DE19744004C1 (en) * 1997-09-26 1999-07-22 Schering Ag Lipophilic metal complexes for necrosis and infarct imaging

Also Published As

Publication number Publication date
CA2419259A1 (en) 2002-02-21
AU2001279777B2 (en) 2006-08-31
CN1468113A (en) 2004-01-14
HUP0300769A2 (en) 2003-09-29
SK1552003A3 (en) 2003-09-11
HRP20030171A2 (en) 2004-06-30
NO20030649L (en) 2003-04-11
PL365367A1 (en) 2004-12-27
KR20080027397A (en) 2008-03-26
EP1307237A2 (en) 2003-05-07
DE10040858C2 (en) 2003-12-18
YU10503A (en) 2006-08-17
DE10040858A1 (en) 2002-03-28
RU2289579C2 (en) 2006-12-20
CZ2003341A3 (en) 2003-05-14
BR0113187A (en) 2003-07-01
AR035342A1 (en) 2004-05-12
ATE359093T1 (en) 2007-05-15
KR20030022381A (en) 2003-03-15
DE50112336D1 (en) 2007-05-24
ES2284671T3 (en) 2007-11-16
UY26873A1 (en) 2002-03-22
UA74004C2 (en) 2005-10-17
JP2004506026A (en) 2004-02-26
EP1307237B9 (en) 2008-01-09
SK286239B6 (en) 2008-06-06
NO20030649D0 (en) 2003-02-10
IL154329A0 (en) 2003-09-17
WO2002013875A3 (en) 2002-08-22
ZA200301947B (en) 2004-06-25
AU7977701A (en) 2002-02-25
HUP0300769A3 (en) 2009-03-02
EP1307237B1 (en) 2007-04-11
BG107541A (en) 2004-01-30
EE200300060A (en) 2004-12-15
NZ524080A (en) 2005-10-28
PT1307237E (en) 2007-07-02
WO2002013875A2 (en) 2002-02-21
MXPA03001286A (en) 2004-04-20

Similar Documents

Publication Publication Date Title
NO20012158D0 (en) Substituted 2-phenylbenzimidazoles, process for preparation and use thereof
DK1180518T3 (en) 5-pyridyl-1,3-azole compounds, process for their preparation and use thereof
HK1061679A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-ibe derivatives, their preparation and their therapeutic use.
NO20021449D0 (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
NO20024281D0 (en) Indole derivatives, processes for preparing the same and their use
NO20012567D0 (en) Azepinoindole derivatives, preparation and use thereof
MXPA03005713A (en) Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors.
NO20053809D0 (en) Diarylmethylindenepiperidine derivatives, process for their preparation, and use thereof
NO20030800L (en) Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, process and preparation containing the same
EE200300245A (en) Benzothiophene derivatives, process for their preparation and use
NO20031838D0 (en) Benzocazine derivatives, their preparation and use
DK1334106T3 (en) Imidazole derivatives, their preparation methods and their use
DK1417189T3 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
NO20026128L (en) Gel-shaped fuel, process for its preparation and its use
DK1307237T3 (en) Perfluoroalkyl-containing complexes with polar groups, process for their preparation and use
DK1307446T3 (en) Perfluoroalkyl-containing complexes with sugar residues, process for their preparation and use
DK1163231T3 (en) Perfluoroalkylamides, their preparation and their use in diagnostics
NO20033120L (en) 2-arylimino-2,3-dihydrotiazole derivatives, processes for their preparation and therapeutic use thereof
NO20053805D0 (en) Diarylmethylindenepiperidine derivatives, processes for their preparation, and use thereof
DK1086077T3 (en) New antiestrogens, methods for their preparation and their pharmaceutical use
NO20024105D0 (en) Memnopeptides, Methods for their Preparation and Use
NO20025209L (en) Cyclipostins, their preparation and use
NO20024107L (en) Tienopyridine derivatives, their preparation and use
MXPA03006162A (en) Mikanolide derivatives, their preparation and therapeutic uses.
NO20042768L (en) IFNAR2 mutants, their preparation and use